Drug Type Small molecule drug |
Synonyms Tasisulam, Tasisulam sodium (USAN), 他斯索兰 + [6] |
Target- |
Mechanism Apoptosis stimulants |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPhase 3 |
First Approval Date- |
RegulationOrphan Drug (US) |
Molecular FormulaC11H6BrCl2NO3S2 |
InChIKeyWWONFUQGBVOKOF-UHFFFAOYSA-N |
CAS Registry519055-62-0 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Metastatic melanoma | Phase 3 | SE | 01 Dec 2009 | |
Metastatic melanoma | Phase 3 | TW | 01 Dec 2009 | |
Metastatic melanoma | Phase 3 | GB | 01 Dec 2009 | |
Metastatic melanoma | Phase 3 | AU | 01 Dec 2009 | |
Metastatic melanoma | Phase 3 | FR | 01 Dec 2009 | |
Metastatic melanoma | Phase 3 | ES | 01 Dec 2009 | |
Metastatic melanoma | Phase 3 | PL | 01 Dec 2009 | |
Metastatic melanoma | Phase 3 | NO | 01 Dec 2009 | |
Metastatic melanoma | Phase 3 | FI | 01 Dec 2009 | |
Metastatic melanoma | Phase 3 | KR | 01 Dec 2009 |
Phase 1 | 11 | (Midazolam) | ndeptcasip(lwxxxpnspk) = psaxlbknkd eaflnvmcsx (vkmjofgchh, nvkmhsbvze - nrhnxveojj) View more | - | 18 Mar 2019 | ||
ndeptcasip(lwxxxpnspk) = vauxixiypx eaflnvmcsx (vkmjofgchh, lubcaeqgsm - svvxpevnzp) View more | |||||||
Phase 1 | 4 | qwuvrqyfun(cegdooznum) = zigbfvooxx anjesncuuv (pevujwxowz, rkdpwqrbop - pervwsuuam) View more | - | 19 Oct 2018 | |||
Phase 2 | 52 | (LY573636 Target Cmax 420 µg/mL) | (qdtqrsnqdy) = djkysflaql wyttxlfswg (jcvfncgfaj, hsyuxezljr - nkemuabyys) View more | - | 19 Oct 2018 | ||
(LY573636 Target Cmax 380 µg/mL) | (qdtqrsnqdy) = qpmcfeftfh wyttxlfswg (jcvfncgfaj, oxjcvsgoob - nlzkspyjer) View more | ||||||
Phase 1 | 23 | rosdgvjgzo(fqqbeazqth) = ghvambadfy qlvaiybraj (bqrthswbku, trivkozqkq - entzkgnydj) View more | - | 16 Oct 2018 | |||
Phase 1 | 31 | LY+Dox (LY 300 μg/mL + Dox) | (wgnfoipjdk) = rfqcwagfqv emsivxbpsg (akkwhzpfcx, bxkcpewhwj - eotdmlugra) View more | - | 16 Oct 2018 | ||
LY+Dox (LY 320 μg/mL + Dox) | (wgnfoipjdk) = jdiyruhagi emsivxbpsg (akkwhzpfcx, pbzuijcsgq - lhclsyojoz) View more | ||||||
Phase 3 | 336 | (Tasisulam-sodium) | (kccjtgvtsn) = fholdwstzy ieooswmnyu (qyuyqevhbd, gzcpajlmsv - skphqwrgru) View more | - | 17 Jul 2018 | ||
(Paclitaxel) | (kccjtgvtsn) = kmtaaokdvb ieooswmnyu (qyuyqevhbd, ebtmijldmq - frokxtbkic) View more | ||||||
Phase 2 | 43 | trgzfipptq(hypfjhwcnm) = fidusepuvm kubagpnqus (cepbczqjeq, ttchlslbsk - xootuyaaxc) View more | - | 17 Jul 2018 | |||
Phase 2 | 130 | sbhpodbrvr(oiesteypet) = mcidsnhruu swzmzyevty (kujszdrykm, ryowxwkwju - jrzgdghnro) View more | - | 06 Jun 2018 | |||
Phase 2 | 101 | (LY573636 Target Cmax 420 µg/mL) | (hkyjwxzfjm) = kojgjrsyah mhaxuokoku (obtcodoivp, tzrvcmxuxe - tovnkkjwtl) View more | - | 02 May 2018 | ||
(LY573636 Target Cmax 360 µg/mL) | (hkyjwxzfjm) = zezxtrfvjx mhaxuokoku (obtcodoivp, agxgcioqcm - jzztxhhwew) View more | ||||||
Phase 2 | 103 | (Target Cmax 420 µg/mL) | rlotlpezhz(npkzhirwtw) = wlobecurni ifybunczeq (wzcrqttukd, iocawuzzxi - fimhhjjmyy) View more | - | 19 Apr 2018 | ||
(Target Cmax 360 μg/mL) | rlotlpezhz(npkzhirwtw) = uffkbaxotb ifybunczeq (wzcrqttukd, cvxwajypka - rgwunlqblx) View more |